Clinical trials: Rokitansky Kuster Hauser Syndrome
Mayer Rokitansky Kuster Hauser Syndrome
Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome
In order to understand the molecular mechanisms leading to Mayer-Rokitansky-Kuster-Hauser syndrome (MRKH), the research team has to identify molecular bases of this anomaly.
- Trial name
- MRKH (NCT02967822)
- Testing
- Biological samples for patients, Biological samples for healthy relatives
- Where
- 2 sites in France
- Volunteers
- 410 people, healthy volunteers welcome
- Sponsor
- Imagine Institute
Mrk Anomaly, Infertility, Female
Uterus Transplantation LD - Feasibility Study - Sahlgrenska - BMC
Medical know-how concerning uterus transplantation will be transferred to new site by structured process involving theory, animal workshops and a clinical feasibility study on human subjects.
- Trial name
- GOT-BMC-UTx (NCT03590405)
- Testing
- uterus transplantation surgery and IVF
- Where
- 2 sites in Sweden
- Volunteers
- 2 people, healthy volunteers welcome
- Sponsor
- Sahlgrenska University Hospital
Mayer Rokitansky Kuster Hauser Syndrome
Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)
In France, one in 4500 women is affected by the MayerRokitantskyKüsterHauser (MRKH) syndrome which is characterized by the absence of uterus at birth.
- Trial name
- NCT03689842
- Testing
- Uterine transplantation
- Where
- France
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Hopital Foch
Mrkh Syndrome
Evaluation of the Quality of Life and Gynecological Follow-up of Patients Treated for Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome
Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome affects 1 in 4,500 women and consists of utero-vaginal aplasia in 46 chromosom XX women, most often diagnosed in the presence of primary amenorrhea.
- Trial name
- MOQA (NCT07186764)
- Testing
- Questionnaires, Semi-directed interview
- Where
- France
- Volunteers
- 102 people, healthy volunteers welcome
- Sponsor
- University Hospital, Toulouse
Mayer Rokitansky Kuster Hauser Syndrome, Uterine Agenesis
The University of Pennsylvania Uterus Transplant for Uterine Factor Infertility Trial
Options for childbearing are limited for the thousands of women in the United States who suffer from absolute uterine factor infertility. Uterine transplantation is an emerging treatment that provides hope for these individuals.
- Conditions
- Mayer Rokitansky Kuster Hauser Syndrome, Uterine Agenesis, Infertility, Female, of Uterine Origin, Uterine Factor Infertility
- Trial name
- UNTIL (NCT03307356)
- Testing
- Uterine Transplant
- Where
- United States
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- University of Pennsylvania